Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
2.410
-0.130 (-5.12%)
At close: Jun 12, 2025, 4:00 PM
2.380
-0.030 (-1.24%)
Pre-market: Jun 13, 2025, 9:01 AM EDT

Humacyte Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
374650294218747131
Upgrade
Market Cap Growth
-28.59%120.90%35.19%-70.86%471.21%-
Upgrade
Enterprise Value
3947092519754939
Upgrade
Last Close Price
2.415.052.842.117.2510.17
Upgrade
PS Ratio
723.09--139.03591.2787.68
Upgrade
PB Ratio
10.37-12.3421.721.866.111.85
Upgrade
P/TBV Ratio
10.37-21.721.866.11-
Upgrade
EV/Sales Ratio
761.12--61.82434.3125.88
Upgrade
Debt / Equity Ratio
2.29-1.544.290.430.420.41
Upgrade
Asset Turnover
0.00--0.010.010.01
Upgrade
Quick Ratio
3.162.254.367.7620.423.57
Upgrade
Current Ratio
3.682.404.517.8820.763.69
Upgrade
Return on Equity (ROE)
-249.75%--169.81%-10.01%-27.46%-65.58%
Upgrade
Return on Assets (ROA)
-42.82%-53.74%-36.44%-21.54%-25.81%-29.32%
Upgrade
Return on Capital (ROIC)
-62.70%-142.57%-50.66%-31.01%-37.20%-31.18%
Upgrade
Earnings Yield
-21.41%-22.88%-37.66%-5.50%-3.55%-50.88%
Upgrade
FCF Yield
-26.96%-15.34%-25.70%-33.17%-10.90%-42.75%
Upgrade
Buyback Yield / Dilution
-18.75%-14.56%-0.36%-157.82%-593.25%71.34%
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q